Fig. 4 | Scientific Reports

Fig. 4

From: Real-World pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database

Fig. 4

Forest plots of different agents inducing conjunctivitis under BCPNN classification. Ten drugs were ranked according to their BCPNN values, allowing us to classify them into two association categories: high and low. High association drugs include tralokinumab, brimonidine, dupilumab and latanoprost. Low association drugs include allopurinol, cetuximab, canakinumab, ondansetron, lamotrigine and erlotinib.

Back to article page